Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gareth Peter Gregory (Gareth P Gregory, Gareth Gregory)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

Blood advances

Internal medicine journal

Nature communications

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy L Bartlett, Sarit Assouline, Pratyush Giri, Stephen J Schuster, Chan Yoon Y Cheah, Matthew J Matasar, Gareth Peter Gregory, Dok-Hyun Yoon, Mazyar Shadman, Keith Fay, Sung Soo Yoon, Carlos Panizo, Ian W Flinn, Anna M Johnston, Francesc Bosch, Laurie H Sehn, Michael C Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, L Elizabeth Elizabeth Budde
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma. Blood advances (2023)
Maciej Tatarczuch, Mark Waltham, Jake Shortt, Galina Polekhina, Eliza A Hawkes, Shir-Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen Samuel Opat, Gareth Peter Gregory
Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma. Blood advances (2023)
Pietro R Di Ciaccio, Georgia Mills, Michael J Shipton, Belinda A Campbell, Gareth Peter Gregory, Jenna Langfield, Matthew Greenwood, Sean J McKeague, Mohammad Shanavas, Renee Eslick, Giselle Kidson-Gerber, Portia Smallbone, Catherine Tang, Kirk Morris, Ian Bilmon, Costas K Yannakou, Xavier Badoux, Leanne Berkahn, Sergio Farina, Kylie D Mason, Penelope Motum, Kathryn Goss, Nada Hamad
The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance. British journal of haematology (2023)
Jemima H Miller, Michael Gilbertson, Michael P MacManus, Andrew Wirth, Stephen Samuel Opat, Gareth Peter Gregory
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL. Blood advances 5 (23) (2022)
Colm Keane, Nada Hamad, Allison Barraclough, Yoo Y Lee, Dipti Talaulikar, Matthew Ku, Joel Wight, Maciej Tatarczuch, Fiona Swain, Gareth Peter Gregory
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal medicine journal 52 (9) (2022)
Gareth Peter Gregory, Shaji K Kumar, Ding Wang, Daruka Mahadevan, Patricia Walker, Nina D Wagner-Johnston, Carolina Escobar, Rajat Bannerji, Divaya Bhutani, Julie Chang, Francisco J Hernandez-Ilizaliturri, Andreas Klein, John M Pagel, Witold B Rybka, Andrew J Yee, Anne Mohrbacher, Mo Huang, Mohammed Farooqui, Patricia Marinello, Hang Quach
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood advances 6 (4) (2022)
Constantine S Tam, Gareth Peter Gregory, Matthew Ku, Shaun Fleming, Sasanka M Handunnetti, Denise Lee, Patricia Walker, Andrew Perkins, Thomas E Lew, Shreerang Sirdesai, Chong Chyn Chua, Michael Gilbertson, Masa Lasica, Mary Ann Anderson, William Renwick, Andrew Grigg, Sush Patil, Stephen Opat, Adam Friebe, Rachel Cooke, Jasper De Boer, Andrew Spencer, David Ritchie, Rishu Agarwal, Piers Blombery
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre. Internal medicine journal 52 (7) (2022)
Briony Shaw, Jake Shortt, Michael Low, Benjamin Rogers, Zane Kaplan, Pasquale Fedele, Gareth Peter Gregory, Shahla Vilcassim, Michael Gilbertson, George Grigoriadis, Stephen Opat
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2. Internal medicine journal (2022)
Ross Thomas Salvaris, Jeremy Ong, Gareth Peter Gregory
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas. Journal of personalized medicine 11 (5) (2021)
Stefan Bjelosevic, Emily Gruber, Andrea Newbold, Carolyn Shembrey, Jennifer R Devlin, Simon J Hogg, Lev M Kats, Izabela Todorovski, Zheng Fan, Thomas C Abrehart, Giovanna Pomilio, Andrew Wei, Gareth Peter Gregory, Stephin J Vervoort, Kristin K Brown, Ricky W Johnstone
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid Leukemia. Cancer discovery 11 (6) (2021)
Srividya B Balachander, Steven W Criscione, Kate F Byth, Justin Cidado, Ammar Adam, Paula Lewis, Terry Macintyre, Shenghua Wen, Deborah Lawson, Kathleen Burke, Tristan Lubinski, Jeffrey W Tyner, Stephen E Kurtz, Shannon K McWeeney, Jeffrey Varnes, R Bruce Diebold, Thomas Gero, Stephanos Ioannidis, Edward J Hennessy, William McCoull, Jamal C Saeh, Areya Tabatabai, Omid Tavana, Nancy Su, Alwin Schuller, Mathew J Garnett, Patricia Jaaks, Elizabeth A Coker, Gareth Peter Gregory, Andrea Newbold, Ricky W Johnstone, Eric Gangl, Martin Wild, Michael Zinda, J Paul Secrist, Barry R Davies, Stephen E Fawell, Francis D Gibbons
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Jonathan Wing Kit Wong, Meaghan Wall, Gregory Philip Corboy, Nadine Taubenheim, Gareth Peter Gregory, Stephen Samuel Opat, Jake Shortt
Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations. Cold Spring Harbor molecular case studies 6 (4) (2020)
Zheng Fan, Jennifer R Devlin, Simon J Hogg, Maria A Doyle, Paul F Harrison, Izabela Todorovski, Leonie A Cluse, Deborah A Knight, Jarrod J Sandow, Gareth Peter Gregory, Andrew Fox, Traude H Beilharz, Nicholas Kwiatkowski, Nichollas E Scott, Ana Tufegdzic Vidakovic, Gavin P Kelly, Jesper Q Svejstrup, Matthias Geyer, Nathanael S Gray, Stephin J Vervoort, Ricky W Johnstone
CDK13 cooperates with CDK12 to control global RNA polymerase II processivity. Science advances 6 (18) (2020)
Gareth Peter Gregory, Christine Carrington, Chan Y Cheah, Eliza A Hawkes, Ian M Irving, Jim Siderov, Stephen Opat
A consensus statement on the use of biosimilar medicines in hematology in Australia. Asia-Pacific journal of clinical oncology 16 (4) (2020)
Maciej Tatarczuch, Erin Paul, Michael Gilberston, Gareth Peter Gregory, Constantine S Tam, Hang Quach, Ali Bazargan, Robin Filshie, Matthew Ku, Amanda Tey, Jake Shortt, Stephen Samuel Opat
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy. Leukemia & lymphoma 62 (1) (2020)
Madison J Kelly, Joan So, Amy J Rogers, Gareth Peter Gregory, Jason Li, Magnus Zethoven, Micah D Gearhart, Vivian J Bardwell, Ricky W Johnstone, Stephin J Vervoort, Lev M Kats
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis. Nature communications 10 (1) (2019)
Darren C Phillips, Sha Jin, Gareth Peter Gregory, Qi Zhang, John Xue, Xiaoxian Zhao, Jun Chen, Yunsong Tong, Haichao Zhang, Morey Smith, Stephen K Tahir, Rick F Clark, Thomas D Penning, Jennifer R Devlin, Jake Shortt, Eric D Hsi, Daniel H Albert, Marina Konopleva, Ricky W Johnstone, Joel D Leverson, Andrew J Souers
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies. Leukemia 34 (6) (2019)
Adriana E Tron, Matthew A Belmonte, Ammar Adam, Brian M Aquila, Lawrence H Boise, Elisabetta Chiarparin, Justin Cidado, Kevin J Embrey, Eric Gangl, Francis D Gibbons, Gareth Peter Gregory, David Hargreaves, J Adam Hendricks, Jeffrey W Johannes, Ricky W Johnstone, Steven L Kazmirski, Jason G Kettle, Michelle L Lamb, Shannon M Matulis, Ajay K Nooka, Martin J Packer, Bo Peng, Philip B Rawlins, Daniel W Robbins, Alwin G Schuller, Nancy Su, Wenzhan Yang, Qing Ye, Xiaolan Zheng, J Paul Secrist, Edwin A Clark, David M Wilson, Stephen E Fawell, Alexander W Hird
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nature communications 9 (1) (2018)

Gareth Peter Gregory.css-eqlu8i{font-size:small;padding-left:4px;} (Gareth P Gregory, Gareth Gregory)

Publication Activity (10 Years)

Top Topics

Top Venues

Gareth Peter Gregory (Gareth P Gregory, Gareth Gregory)